Pt Kalbe Farma Stock Price Prediction
| PTKFF Stock | USD 0.1 0.01 13.55% |
Oversold Vs Overbought
66
Oversold | Overbought |
Using PT Kalbe hype-based prediction, you can estimate the value of PT Kalbe Farma from the perspective of PT Kalbe response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PT Kalbe to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying PTKFF because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PT Kalbe after-hype prediction price | USD 0.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PTKFF |
PT Kalbe After-Hype Price Prediction Density Analysis
As far as predicting the price of PT Kalbe at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PT Kalbe or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of PT Kalbe, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PT Kalbe Estimiated After-Hype Price Volatility
In the context of predicting PT Kalbe's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PT Kalbe's historical news coverage. PT Kalbe's after-hype downside and upside margins for the prediction period are 0.01 and 2.92, respectively. We have considered PT Kalbe's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PT Kalbe is out of control at this time. Analysis and calculation of next after-hype price of PT Kalbe Farma is based on 3 months time horizon.
PT Kalbe Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as PT Kalbe is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PT Kalbe backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PT Kalbe, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 2.82 | 0.00 | 0.24 | 0 Events / Month | 6 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.1 | 0.10 | 5.15 |
|
PT Kalbe Hype Timeline
PT Kalbe Farma is at this time traded for 0.1. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.24. PTKFF is forecasted to increase in value after the next headline, with the price projected to jump to 0.1 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 5.15%, whereas the daily expected return is at this time at -0.19%. The volatility of related hype on PT Kalbe is about 221.57%, with the expected price after the next announcement by competition of -0.14. PT Kalbe Farma has accumulated about 189.29 M in cash with 2.83 T of positive cash flow from operations. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out PT Kalbe Basic Forecasting Models to cross-verify your projections.PT Kalbe Related Hype Analysis
Having access to credible news sources related to PT Kalbe's direct competition is more important than ever and may enhance your ability to predict PT Kalbe's future price movements. Getting to know how PT Kalbe's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PT Kalbe may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMGN | Amgen Inc | (7.83) | 8 per month | 0.00 | (0.16) | 1.67 | (1.90) | 9.43 | |
| BMY | Bristol Myers Squibb | (1.94) | 8 per month | 1.23 | 0.09 | 2.23 | (2.07) | 14.39 | |
| RHHVF | Roche Holding AG | 0.00 | 0 per month | 0.00 | (0.25) | 1.79 | (2.72) | 5.43 | |
| NVSEF | Novartis AG | 0.00 | 0 per month | 0.00 | (0.14) | 5.28 | (3.80) | 12.02 | |
| SCLXW | Scilex Holding | (0.03) | 4 per month | 12.01 | 0.07 | 36.00 | (19.44) | 109.99 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.00 | (0.26) | 1.20 | (2.76) | 7.58 | |
| NVS | Novartis AG ADR | (0.16) | 11 per month | 0.00 | (0.32) | 1.12 | (1.98) | 6.05 | |
| SCLX | Scilex Holding | 0.04 | 10 per month | 0.00 | (0.20) | 9.38 | (10.20) | 29.49 | |
| AZN | AstraZeneca PLC ADR | (0.58) | 9 per month | 0.00 | (0.35) | 1.28 | (3.18) | 8.50 | |
| HZNP | Horizon Pharma PLC | 0.00 | 0 per month | 0.00 | (0.14) | 1.13 | (0.87) | 16.07 | |
| GILD | Gilead Sciences | (3.50) | 8 per month | 1.00 | 0.11 | 2.17 | (1.82) | 10.80 |
PT Kalbe Additional Predictive Modules
Most predictive techniques to examine PTKFF price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PTKFF using various technical indicators. When you analyze PTKFF charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PT Kalbe Predictive Indicators
The successful prediction of PT Kalbe stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PT Kalbe Farma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PT Kalbe based on analysis of PT Kalbe hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PT Kalbe's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PT Kalbe's related companies.
Story Coverage note for PT Kalbe
The number of cover stories for PT Kalbe depends on current market conditions and PT Kalbe's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PT Kalbe is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PT Kalbe's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
PT Kalbe Short Properties
PT Kalbe's future price predictability will typically decrease when PT Kalbe's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PT Kalbe Farma often depends not only on the future outlook of the potential PT Kalbe's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PT Kalbe's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.9 B |
Complementary Tools for PTKFF Pink Sheet analysis
When running PT Kalbe's price analysis, check to measure PT Kalbe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Kalbe is operating at the current time. Most of PT Kalbe's value examination focuses on studying past and present price action to predict the probability of PT Kalbe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Kalbe's price. Additionally, you may evaluate how the addition of PT Kalbe to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |